TCM

TCG Crossover Management Portfolio holdings

AUM $876M
This Quarter Return
-2.87%
1 Year Return
+23.66%
3 Year Return
+996.72%
5 Year Return
–
10 Year Return
–
AUM
$214M
AUM Growth
–
Cap. Flow
+$214M
Cap. Flow %
100%
Top 10 Hldgs %
83.52%
Holding
15
New
15
Increased
–
Reduced
–
Closed
–

Top Buys

1
ISEE
IVERIC bio, Inc. Common Stock
ISEE
$29.1M
2
VRDN icon
Viridian Therapeutics
VRDN
$26M
3
COGT icon
Cogent Biosciences
COGT
$23.6M
4
CBAY
Cymabay Therapeutics
CBAY
$20M
5
ALPN
Alpine Immune Sciences, Inc. Common Stock
ALPN
$16.2M

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ISEE
1
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$29.1M 13.63%
+1,741,228
New +$29.1M
VRDN icon
2
Viridian Therapeutics
VRDN
$1.5B
$26M 12.16%
+1,314,000
New +$26M
COGT icon
3
Cogent Biosciences
COGT
$1.69B
$23.6M 11.05%
+2,750,037
New +$23.6M
CBAY
4
DELISTED
Cymabay Therapeutics
CBAY
$20M 9.35%
+5,905,400
New +$20M
ALPN
5
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
$16.2M 7.59%
+1,170,212
New +$16.2M
ACRS icon
6
Aclaris Therapeutics
ACRS
$209M
$15.7M 7.37%
+1,082,213
New +$15.7M
KDNY
7
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$14.4M 6.74%
+882,353
New +$14.4M
TYRA icon
8
Tyra Biosciences
TYRA
$675M
$12M 5.6%
+850,450
New +$12M
TRDA icon
9
Entrada Therapeutics
TRDA
$208M
$11.4M 5.32%
+663,694
New +$11.4M
JBIO
10
Jade Biosciences, Inc. Common Stock
JBIO
$258M
$10.1M 4.71%
+853,330
New +$10.1M
DNTH icon
11
Dianthus Therapeutics
DNTH
$759M
$9.84M 4.61%
+2,222,222
New +$9.84M
AKUS
12
DELISTED
Akouos, Inc. Common Stock
AKUS
$8.88M 4.16%
+1,045,215
New +$8.88M
MRUS icon
13
Merus
MRUS
$4.98B
$7.16M 3.35%
+225,000
New +$7.16M
ZLAB icon
14
Zai Lab
ZLAB
$3.68B
$5.97M 2.8%
+95,000
New +$5.97M
ELEV
15
DELISTED
Elevation Oncology
ELEV
$3.34M 1.56%
+555,000
New +$3.34M